Cite Filings / DFTX / 0000950170-25-034176

Feed Companies Filings Check

Sign in

10-K

Annual Report

Definium Therapeutics, Inc. Filed 2025-03-06 Acc 0000950170-25-034176

Documents 1

10-K Annual Report , mnmd-20241231.htm

Around this filing

2026-02-26 10-K Annual Report
2025-03-13 4 Chief Executive Officer acquired 350,000 shares (grant or award)
2025-03-13 4 Chief Medical Officer acquired 115,000 shares (grant or award)
2025-03-13 4 Chief Legal Officer acquired 150,000 shares (grant or award)
2025-03-06 10-K Annual Report
2025-03-06 8-K Results of operations
2024-02-28 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading mnmd-20241231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…